← Research ProtocolsHexarelin
STUDIED EXPOSURE MAP / 1996
Hexarelin
tested in research.
The actual doses, concentrations or exposure levels reported by the source — kept attached to route, population, timeframe and evidence type.
HUMAN / DOSE RESPONSEJ CLIN ENDOCRINOL METABSTUDIED EXPOSURE ≠ RECOMMENDED DOSE
STUDIED EXPOSURE / SOURCE DATANumbers below describe this research source only.
0–1.0 µg/kg
IV dose-response range
Context: The source tested a dose-response range up to 1.0 µg/kg IV. This is acute endocrine pharmacology, not a recommended subcutaneous protocol.
NOT A DOSING GUIDEENHANCED is reporting what researchers administered or tested. It does not convert these numbers into a personal dose, reconstitution plan, cycle, titration schedule or recommendation.
SOURCE / J CLIN ENDOCRINOL METAB
Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study
Study design and tested exposure are separated from recommendation. Route and population stay visible so the numbers cannot be read without context.
1996
01 / DESIGNHuman dose-response endocrine study
02 / POPULATION / MODELHealthy adult males
03 / ROUTEIntravenous
04 / TIMEFRAMEAcute endocrine-response study
05 / PRIMARY QUESTIONGH, prolactin and cortisol release
It supports a factual statement about the exposure tested in this research source. It does not establish that the same exposure is appropriate, effective or safe outside that source.
Broader research index. This entity is not presented here as an ENHANCED catalogue compound.
Study exposure ≠ personal protocol. Animal doses are never converted to human-equivalent amounts here. IV, topical, oral, intranasal and subcutaneous exposures are not treated as interchangeable.